Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
13,285,733
-
Share change
-
+4,091,160
-
Total reported value
-
$294,926,000
-
Price per share
-
$22.20
-
Number of holders
-
54
-
Value change
-
+$91,937,002
-
Number of buys
-
39
-
Number of sells
-
20
Institutional Holders of NEURODERM LTD - ORD SHS as of Q4 2016
As of 31 Dec 2016,
NEURODERM LTD - ORD SHS was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,285,733 shares.
The largest 10 holders included
SCOPIA CAPITAL MANAGEMENT LP, Redmile Group, LLC, venBio Select Advisor LLC, ACUTA CAPITAL PARTNERS, LLC, MENORA MIVTACHIM HOLDINGS LTD., ADAGE CAPITAL PARTNERS GP, L.L.C., BAKER BROS. ADVISORS LP, FRANKLIN RESOURCES INC, Sectoral Asset Management Inc, and MILLENNIUM MANAGEMENT LLC.
This page lists
54
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.